Songlin Xue | Executive Vice President and Global Head of Pharmacovigilance
Astellas

Songlin Xue, Executive Vice President and Global Head of Pharmacovigilance, Astellas

Appearances:



Drug Safety World Day 2 @ 09:40

Mitigating the effects of dramatic changes to big data and safety technology

  • Strategies for streamlining uptake of new PV technology and ensuring seamless responses to the resulting changes
  • Assessing the impact of new signal detection methodologies implemented by the FDA
  • Collaborating with wide networks of colleagues and vendors to harmonize uptake of new technologies in PV

back to speakers